Research ArticleArticle
Improvement in Psoriasis Signs and Symptoms Assessed by the Psoriasis Symptom Inventory with Brodalumab Treatment in Patients with Psoriatic Arthritis
Philip J. Mease, Mark C. Genovese, Alex Mutebi, Hema N. Viswanathan, Dina Chau, Jingyuan Feng, Ngozi Erondu and Ajay Nirula
The Journal of Rheumatology January 2016, jrheum.150182; DOI: https://doi.org/10.3899/jrheum.150182
Philip J. Mease
From the Swedish Medical Center; University of Washington, Seattle, Washington; Stanford University, Stanford; Amgen Inc., Thousand Oaks, California, USA. Study funded by Amgen Inc. PJM has received research grants, consulting fees, and/or speaker honoraria from Amgen Inc. MCG has received research grants and consulting fees from Amgen Inc. AM, HNV, and DC are employees and shareholders of Amgen Inc. JF, NE, and AN are former employees and shareholders of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; M.C. Genovese, MD, Stanford University; A. Mutebi, PhD, Amgen Inc.; H.N. Viswanathan, PhD, Amgen Inc.; D. Chau, PharmD, Amgen Inc.; J. Feng, MS, formerly with Amgen Inc.; A. Nirula, MD, PhD, formerly with Amgen Inc.; N. Erondu, PhD, formerly with Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication August 31, 2015.
Mark C. Genovese
From the Swedish Medical Center; University of Washington, Seattle, Washington; Stanford University, Stanford; Amgen Inc., Thousand Oaks, California, USA. Study funded by Amgen Inc. PJM has received research grants, consulting fees, and/or speaker honoraria from Amgen Inc. MCG has received research grants and consulting fees from Amgen Inc. AM, HNV, and DC are employees and shareholders of Amgen Inc. JF, NE, and AN are former employees and shareholders of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; M.C. Genovese, MD, Stanford University; A. Mutebi, PhD, Amgen Inc.; H.N. Viswanathan, PhD, Amgen Inc.; D. Chau, PharmD, Amgen Inc.; J. Feng, MS, formerly with Amgen Inc.; A. Nirula, MD, PhD, formerly with Amgen Inc.; N. Erondu, PhD, formerly with Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication August 31, 2015.
Alex Mutebi
From the Swedish Medical Center; University of Washington, Seattle, Washington; Stanford University, Stanford; Amgen Inc., Thousand Oaks, California, USA. Study funded by Amgen Inc. PJM has received research grants, consulting fees, and/or speaker honoraria from Amgen Inc. MCG has received research grants and consulting fees from Amgen Inc. AM, HNV, and DC are employees and shareholders of Amgen Inc. JF, NE, and AN are former employees and shareholders of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; M.C. Genovese, MD, Stanford University; A. Mutebi, PhD, Amgen Inc.; H.N. Viswanathan, PhD, Amgen Inc.; D. Chau, PharmD, Amgen Inc.; J. Feng, MS, formerly with Amgen Inc.; A. Nirula, MD, PhD, formerly with Amgen Inc.; N. Erondu, PhD, formerly with Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication August 31, 2015.
Hema N. Viswanathan
From the Swedish Medical Center; University of Washington, Seattle, Washington; Stanford University, Stanford; Amgen Inc., Thousand Oaks, California, USA. Study funded by Amgen Inc. PJM has received research grants, consulting fees, and/or speaker honoraria from Amgen Inc. MCG has received research grants and consulting fees from Amgen Inc. AM, HNV, and DC are employees and shareholders of Amgen Inc. JF, NE, and AN are former employees and shareholders of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; M.C. Genovese, MD, Stanford University; A. Mutebi, PhD, Amgen Inc.; H.N. Viswanathan, PhD, Amgen Inc.; D. Chau, PharmD, Amgen Inc.; J. Feng, MS, formerly with Amgen Inc.; A. Nirula, MD, PhD, formerly with Amgen Inc.; N. Erondu, PhD, formerly with Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication August 31, 2015.
Dina Chau
From the Swedish Medical Center; University of Washington, Seattle, Washington; Stanford University, Stanford; Amgen Inc., Thousand Oaks, California, USA. Study funded by Amgen Inc. PJM has received research grants, consulting fees, and/or speaker honoraria from Amgen Inc. MCG has received research grants and consulting fees from Amgen Inc. AM, HNV, and DC are employees and shareholders of Amgen Inc. JF, NE, and AN are former employees and shareholders of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; M.C. Genovese, MD, Stanford University; A. Mutebi, PhD, Amgen Inc.; H.N. Viswanathan, PhD, Amgen Inc.; D. Chau, PharmD, Amgen Inc.; J. Feng, MS, formerly with Amgen Inc.; A. Nirula, MD, PhD, formerly with Amgen Inc.; N. Erondu, PhD, formerly with Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication August 31, 2015.
Jingyuan Feng
From the Swedish Medical Center; University of Washington, Seattle, Washington; Stanford University, Stanford; Amgen Inc., Thousand Oaks, California, USA. Study funded by Amgen Inc. PJM has received research grants, consulting fees, and/or speaker honoraria from Amgen Inc. MCG has received research grants and consulting fees from Amgen Inc. AM, HNV, and DC are employees and shareholders of Amgen Inc. JF, NE, and AN are former employees and shareholders of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; M.C. Genovese, MD, Stanford University; A. Mutebi, PhD, Amgen Inc.; H.N. Viswanathan, PhD, Amgen Inc.; D. Chau, PharmD, Amgen Inc.; J. Feng, MS, formerly with Amgen Inc.; A. Nirula, MD, PhD, formerly with Amgen Inc.; N. Erondu, PhD, formerly with Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication August 31, 2015.
Ngozi Erondu
From the Swedish Medical Center; University of Washington, Seattle, Washington; Stanford University, Stanford; Amgen Inc., Thousand Oaks, California, USA. Study funded by Amgen Inc. PJM has received research grants, consulting fees, and/or speaker honoraria from Amgen Inc. MCG has received research grants and consulting fees from Amgen Inc. AM, HNV, and DC are employees and shareholders of Amgen Inc. JF, NE, and AN are former employees and shareholders of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; M.C. Genovese, MD, Stanford University; A. Mutebi, PhD, Amgen Inc.; H.N. Viswanathan, PhD, Amgen Inc.; D. Chau, PharmD, Amgen Inc.; J. Feng, MS, formerly with Amgen Inc.; A. Nirula, MD, PhD, formerly with Amgen Inc.; N. Erondu, PhD, formerly with Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication August 31, 2015.
Ajay Nirula
From the Swedish Medical Center; University of Washington, Seattle, Washington; Stanford University, Stanford; Amgen Inc., Thousand Oaks, California, USA. Study funded by Amgen Inc. PJM has received research grants, consulting fees, and/or speaker honoraria from Amgen Inc. MCG has received research grants and consulting fees from Amgen Inc. AM, HNV, and DC are employees and shareholders of Amgen Inc. JF, NE, and AN are former employees and shareholders of Amgen Inc. P.J. Mease, MD, Swedish Medical Center and University of Washington; M.C. Genovese, MD, Stanford University; A. Mutebi, PhD, Amgen Inc.; H.N. Viswanathan, PhD, Amgen Inc.; D. Chau, PharmD, Amgen Inc.; J. Feng, MS, formerly with Amgen Inc.; A. Nirula, MD, PhD, formerly with Amgen Inc.; N. Erondu, PhD, formerly with Amgen Inc. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, Washington 98122, USA. E-mail: pmease@philipmease.com. Accepted for publication August 31, 2015.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Improvement in Psoriasis Signs and Symptoms Assessed by the Psoriasis Symptom Inventory with Brodalumab Treatment in Patients with Psoriatic Arthritis
Philip J. Mease, Mark C. Genovese, Alex Mutebi, Hema N. Viswanathan, Dina Chau, Jingyuan Feng, Ngozi Erondu, Ajay Nirula
The Journal of Rheumatology Jan 2016, jrheum.150182; DOI: 10.3899/jrheum.150182
Improvement in Psoriasis Signs and Symptoms Assessed by the Psoriasis Symptom Inventory with Brodalumab Treatment in Patients with Psoriatic Arthritis
Philip J. Mease, Mark C. Genovese, Alex Mutebi, Hema N. Viswanathan, Dina Chau, Jingyuan Feng, Ngozi Erondu, Ajay Nirula
The Journal of Rheumatology Jan 2016, jrheum.150182; DOI: 10.3899/jrheum.150182